Avacta have a platform that can deliver chemo directly to fap rich tumours with next to no side effects. That's got to be worth multiple billions having looked at other deals done recently.
I would have thought to sign of a multi billion dollar buy they will need to see the phase1a data, which we will all get to see in Q4 (this Q). With its evidence of efficacy that so rarely occurs in phase 1 of a trial.
P.s well done all for reporting sheppy and not engaging (too much). And look posts removed and he doesn't dominate the board π